Published in Clin Ophthalmol on January 06, 2011
Ocular pulse amplitude and retinal vessel caliber changes after intravitreal ranibizumab. Int Ophthalmol (2014) 0.82
Does fundus fluorescein angiography procedure affect ocular pulse amplitude? J Ophthalmol (2013) 0.75
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol (2005) 5.56
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A (1996) 5.04
Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol (2004) 4.47
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina (2006) 4.40
Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology (2007) 3.85
Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci (1998) 3.01
Role of the sclera in the development and pathological complications of myopia. Prog Retin Eye Res (2003) 2.71
Ocular blood flow velocity in age-related macular degeneration. Ophthalmology (1995) 2.53
Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol (2005) 2.38
Pulsatile ocular blood flow study: decreases in exudative age related macular degeneration. Br J Ophthalmol (2001) 2.30
Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina (2006) 2.23
Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration. Toxicol Pathol (1999) 1.90
Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol (2007) 1.90
The role of vascular endothelial growth factor in ocular health and disease. Retina (2005) 1.81
Comparison of dynamic contour tonometry with goldmann applanation tonometry. Invest Ophthalmol Vis Sci (2004) 1.78
Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci (1992) 1.69
Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol (1990) 1.66
Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci (2007) 1.64
VEGF expression and receptor activation in the choroid during development and in the adult. Invest Ophthalmol Vis Sci (2006) 1.59
Ocular rigidity in living human eyes. Invest Ophthalmol Vis Sci (2005) 1.54
Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Am J Ophthalmol (1999) 1.46
Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections. J Ocul Pharmacol Ther (2010) 1.46
Dynamic contour tonometry in comparison to intracameral IOP measurements. Invest Ophthalmol Vis Sci (2008) 1.41
Anti-VEGF therapy: comparison of current and future agents. Eye (Lond) (2008) 1.37
Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization. Ophthalmology (2008) 1.37
Increased scleral rigidity and age-related macular degeneration. Ophthalmology (1989) 1.32
Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology (2009) 1.21
Evolution of age-related macular degeneration with choroidal perfusion abnormality. Am J Ophthalmol (1992) 1.15
Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol (2006) 1.11
Comparison of dynamic contour tonometry and goldmann applanation tonometry in glaucoma patients and healthy subjects. Am J Ophthalmol (2006) 1.10
Ocular pulse amplitude in healthy subjects as measured by dynamic contour tonometry. Arch Ophthalmol (2006) 1.09
Reproducibility of measurements with a new slit lamp-mounted ocular blood flow tonograph. Graefes Arch Clin Exp Ophthalmol (1998) 1.09
Refractive error and choroidal perfusion characteristics in patients with choroidal neovascularization and age-related macular degeneration. Ger J Ophthalmol (1993) 1.09
Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci (2010) 1.02
Delayed macular choriocapillary circulation in age-related macular degeneration. Int Ophthalmol (1995) 1.01
Foveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration. Br J Ophthalmol (1995) 0.99
[Ocular pulse amplitude: a new biometrical parameter for the diagnose of glaucoma?]. Ophthalmologe (2007) 0.98
Ocular blood flow measurements in healthy human myopic eyes. Graefes Arch Clin Exp Ophthalmol (2010) 0.97
Ocular pulse amplitude in normal tension and primary open angle glaucoma. J Glaucoma (2008) 0.95
Relationship between ocular pulse amplitude and systemic blood pressure measurements. Acta Ophthalmol (2008) 0.93
Safety evaluation of repeated intravitreal injections of bevacizumab and ranibizumab in rabbit eyes. Retina (2010) 0.89
Comparison of dynamic contour tonometry with Goldmann applanation tonometry in glaucoma practice. Acta Ophthalmol (2008) 0.86
Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol (2009) 0.83
The effects of dorzolamide on choroidal and retinal perfusion in non-exudative age related macular degeneration. Br J Ophthalmol (2003) 0.78
Electrophysiological assessment of retinal function during 6 months of bevacizumab treatment in neovascular age-related macular degeneration. Retina (2010) 0.78
Generic medications in ophthalmology. Br J Ophthalmol (2012) 2.29
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell (2010) 2.26
Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study. Am J Ophthalmol (2007) 2.21
Twenty-four-hour ocular perfusion pressure in primary open-angle glaucoma. Br J Ophthalmol (2010) 2.10
Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki Eye Study. Am J Ophthalmol (2009) 2.09
Pneumatic retinopexy for the repair of primary rhegmatogenous retinal detachment: a 10-year retrospective analysis. JAMA Ophthalmol (2013) 2.02
Ocular perfusion pressure in glaucoma. Acta Ophthalmol (2013) 1.99
Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol (2002) 1.98
Outcomes of repeated pars plana vitrectomy for persistent macular holes. Retina (2013) 1.98
Macular hole surgery with inner limiting membrane peeling, endodrainage, and heavy silicone oil tamponade. Am J Ophthalmol (2008) 1.82
Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki eye study. Am J Ophthalmol (2006) 1.79
Risk factors for primary open-angle glaucoma and pseudoexfoliative glaucoma in the Thessaloniki eye study. Am J Ophthalmol (2011) 1.72
Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up. Graefes Arch Clin Exp Ophthalmol (2009) 1.63
Automatic retinal oximetry. Invest Ophthalmol Vis Sci (2006) 1.62
Update in intracranial pressure evaluation methods and translaminar pressure gradient role in glaucoma. Acta Ophthalmol (2014) 1.55
The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema. Isr Med Assoc J (2006) 1.48
Outcomes of different management options for malignant glaucoma: a retrospective study. Graefes Arch Clin Exp Ophthalmol (2011) 1.46
Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci (2009) 1.40
Pulmonary atresia/ventricular septal defect associated with facial port-wine stain and retinal vascular abnormality: a new constellation or deletion in chromosome 22q11.2? Am J Med Genet A (2005) 1.38
Trypan blue not toxic for retinal pigment epithelium in vitro. Am J Ophthalmol (2003) 1.23
Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand (2002) 1.23
Sub-inner limiting membrane haemorrhage: causes and treatment with vitrectomy. Br J Ophthalmol (2007) 1.22
Dysfunctional regulation of ocular blood flow: A risk factor for glaucoma? Clin Ophthalmol (2008) 1.21
Defective membrane expression of the Na(+)-HCO(3)(-) cotransporter NBCe1 is associated with familial migraine. Proc Natl Acad Sci U S A (2010) 1.14
Choroidal perfusion perturbations in non-neovascular age related macular degeneration. Br J Ophthalmol (2002) 1.13
The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res (2003) 1.13
Comparison of pars plana vitrectomy with and without scleral buckle for the repair of primary rhegmatogenous retinal detachment. Am J Ophthalmol (2011) 1.12
Ocular changes in pregnancy. Obstet Gynecol Surv (2003) 1.11
Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma. Br J Ophthalmol (2012) 1.10
Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study. Acta Ophthalmol Scand (2002) 1.10
Sutureless vitrectomy: evolution and current practices. Br J Ophthalmol (2010) 1.10
Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process. Acta Ophthalmol (2010) 1.09
Use of colour Doppler imaging in ocular blood flow research. Acta Ophthalmol (2011) 1.04
Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol (2003) 1.04
Literature review and meta-analysis of topical carbonic anhydrase inhibitors and ocular blood flow. Surv Ophthalmol (2009) 1.01
The role of different VEGF isoforms in scar formation after glaucoma filtration surgery. Exp Eye Res (2011) 1.01
The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma? Surv Ophthalmol (2008) 1.00
Agreement and accuracy of non-expert ophthalmologists in assessing glaucomatous changes in serial stereo optic disc photographs. Ophthalmology (2010) 1.00
Pharmacologic therapies for diabetic retinopathy and diabetic macular edema. Clin Ophthalmol (2007) 0.99
Variability of the standard reference height and its influence on the stereometric parameters of the heidelberg retina tomograph 3. Invest Ophthalmol Vis Sci (2008) 0.99
Age-related ocular vascular changes. Graefes Arch Clin Exp Ophthalmol (2008) 0.98
Oximetry in glaucoma: correlation of metabolic change with structural and functional damage. Acta Ophthalmol (2013) 0.98
MMPs in the trabecular meshwork: promising targets for future glaucoma therapies? Invest Ophthalmol Vis Sci (2013) 0.98
Macular detachment associated with an optic pit: optical coherence tomography patterns and surgical outcomes. Eur J Ophthalmol (2013) 0.98
The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization. Acta Ophthalmol (2010) 0.96
Age-related macular degeneration and the aging eye. Clin Interv Aging (2008) 0.96
The role of transforming growth factor β in glaucoma and the therapeutic implications. Br J Ophthalmol (2013) 0.96
Comparison of ICare, dynamic contour tonometer, and ocular response analyzer with Goldmann applanation tonometer in patients with glaucoma. Eur J Ophthalmol (2009) 0.95
Retinal oximetry in primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2011) 0.95
Longitudinal assessment of plus disease in retinopathy of prematurity using color Doppler imaging. J AAPOS (2009) 0.95
Ocular pulse amplitude in normal tension and primary open angle glaucoma. J Glaucoma (2008) 0.95
Glaucoma filtration surgery and retinal oxygen saturation. Invest Ophthalmol Vis Sci (2009) 0.94
Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma. Eur J Ophthalmol (2011) 0.93
The safety and efficacy of glaucoma medication in the pediatric population. J Pediatr Ophthalmol Strabismus (2009) 0.92
Retinal oxygen metabolism in healthy subjects and glaucoma patients. Br J Ophthalmol (2014) 0.92
Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki Eye Study. Am J Ophthalmol (2007) 0.92
Characteristics of pseudoexfoliation in the Thessaloniki Eye Study. J Glaucoma (2011) 0.91
Phacoemulsification of cataract in patients receiving Coumadin therapy: ocular and hematologic risk assessment. Am J Ophthalmol (2007) 0.91
Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy. J Cataract Refract Surg (2011) 0.91
Endothelin and its suspected role in the pathogenesis and possible treatment of glaucoma. Curr Eye Res (2011) 0.91
Vitrectomy for idiopathic epiretinal membrane in elderly patients: surgical outcomes and visual prognosis. Curr Eye Res (2011) 0.90
Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis. Ann Surg Oncol (2007) 0.89
Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study. Br J Ophthalmol (2013) 0.89
Lack of spontaneous venous pulsation: possible risk indicator in normal tension glaucoma? Acta Ophthalmol (2012) 0.89
Association of open-angle glaucoma with perfusion pressure status in the Thessaloniki Eye Study. Am J Ophthalmol (2013) 0.89
Vitrectomy with indocyanine green-guided inner limiting membrane peeling for a Q-switched Nd:YAG laser-induced macular hole. Retina (2003) 0.88
Pulsatile ocular blood flow: relationship with flow velocities in vessels supplying the retina and choroid. Br J Ophthalmol (2007) 0.88
Impaired ocular blood flow regulation in patients with open-angle glaucoma and diabetes. Clin Experiment Ophthalmol (2012) 0.88
Macular hole after vitrectomy for primary rhegmatogenous retinal detachment. Retina (2012) 0.88
Effects of exercise on intraocular pressure and ocular blood flow: a review. J Glaucoma (2009) 0.88
An update on retinal circulation assessment technologies. Curr Eye Res (2003) 0.88
Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO). J Glaucoma (2011) 0.87
Stripping of Descemet's membrane while refilling the anterior chamber. Bull Soc Belge Ophtalmol (2008) 0.87
Moderate-angle exotropia: a comparison of unilateral and bilateral rectus muscle recession. Ophthalmic Surg Lasers Imaging (2010) 0.86
Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients. Acta Ophthalmol Scand (2003) 0.86
MMPs in the neuroretina and optic nerve: modulators of glaucoma pathogenesis and repair? Invest Ophthalmol Vis Sci (2014) 0.86
Skin tattoos and the development of uveitis. Acta Ophthalmol (2013) 0.86
Diagnostic compatibility of structural and haemodynamic parameters in open-angle glaucoma patients. Acta Ophthalmol (2007) 0.86
Surrogates for ocular perfusion pressure are not perfect--authors reply. Acta Ophthalmol (2014) 0.86
Color Doppler imaging and ocular pulse amplitude in glaucomatous and healthy eyes. Eur J Ophthalmol (2009) 0.86
AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia. Invest Ophthalmol Vis Sci (2014) 0.85
Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy. Acta Ophthalmol (2009) 0.85
Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant. Expert Opin Pharmacother (2014) 0.85
Ocular circulation in systemic lupus erythematosus. Med Sci Monit (2009) 0.85
Rates of visual field loss before and after trabeculectomy. Acta Ophthalmol (2013) 0.85
Correlation between ocular pulse amplitude measured by dynamic contour tonometer and visual field defects. Graefes Arch Clin Exp Ophthalmol (2008) 0.85
Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration. Case Rep Ophthalmol (2010) 0.84
Retrospective analysis of vitrectomy with and without internal limiting membrane peeling for stage 3 and 4 macular hole. Ophthalmic Surg Lasers Imaging (2004) 0.84
Differences in ocular blood flow in glaucoma between patients of African and European descent. J Glaucoma (2015) 0.84
Corneal laceration by sharp objects in children seven years of age and younger. Cornea (2007) 0.84
ICG angiography-guided photodynamic therapy for large pigment epithelial detachments in age-related macular degeneration. Ophthalmic Surg Lasers Imaging (2006) 0.83
Effects of timolol and dorzolamide on retrobulbar hemodynamics in patients with newly diagnosed primary open-angle glaucoma. Ophthalmologica (2002) 0.83
Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ibalpha gene. Ophthalmology (2004) 0.83
The effect of trabeculectomy on ocular pulse amplitude. Invest Ophthalmol Vis Sci (2009) 0.83
Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. Ophthalmology (2010) 0.83